10H-1,9-diazaphenothiazine and its 10-derivatives: synthesis, characterisation and biological evaluation as potential anticancer agents
Published in Journal of Enzyme Inhibition and Medicinal Chemistry, 2019
Beata Morak-Młodawska, Krystian Pluta, Małgorzata Latocha, Małgorzata Jeleń, Dariusz Kuśmierz, Kinga Suwińska, Aleksander Shkurenko, Zenon Czuba, Magdalena Jurzak
The modifications of the phenothiazine structure with one or two pyridine rings lead to pyridobenzothiazines and dipyridothiazines, respectively. Of the four isomeric pyridobenzothiazines (being 1-aza-, 2-aza-, 3-aza- and 4-azaphenothiazines), the 10-dialkylaminoalkyl derivatives of the 1-aza series (known as prothipendyl, isothipendyl, oxypendyl, cloxypendyl and pipazethate) are still used in the various therapies such as antipsychotic24–26, antihistaminic27,28, and antitussive29 and antiemetic drugs30.